Clinical Manifestations of Psychiatric Patients Who Are Carriers of Tay-Sachs Disease | Citedby Results | Neuropsychobiology | Karger Publishers

Skip to Main Content

Skip Nav Destination

Clinical Manifestations of Psychiatric Patients Who Are Carriers of Tay-Sachs Disease: Possible Role of Psychotropic Drugs

Neuropsychobiology (2000) 41 (3): 127–131.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Ceramide signalling in inherited and multifactorial brain metabolic diseases

Devesh C. Pant
Sergio Aguilera-Albesa
Aurora Pujol

Neurobiology of Disease (2020) 143: 105014.

Congenital and Acquired Disorders Presenting as Psychosis in Children and Young Adults

Sheldon Benjamin
Margo D. Lauterbach
Aimee L. Stanislawski

Child and Adolescent Psychiatric Clinics of North America (2013) 22 (4): 581.

Late onset GM2 gangliosidosis mimicking spinal muscular atrophy

Z. Jamrozik
A. Ługowska
M. Gołębiowski
L. Królicki
J. Mączewska
M. Kuźma-Kozakiewicz

Gene (2013) 527 (2): 679.

Evidence for disruption of sphingolipid metabolism in schizophrenia

Sujatha Narayan
Steven R. Head
Timothy J. Gilmartin
Brian Dean
Elizabeth A. Thomas

Journal of Neuroscience Research (2009) 87 (1): 278.

The Differential Diagnosis of Childhood- and Young Adult-Onset Disorders That Include Psychosis

Margo D. Lauterbach
Aimee L. Stanislawski-Zygaj
Sheldon Benjamin

The Journal of Neuropsychiatry and Clinical Neurosciences (2008) 20 (4): 409.

Increased hexosaminidase activity in antipsychotic-induced extrapyramidal side effects: Possible association with higher occurrence in bipolar disorder patients

Zeliha Tunca
Halil Resmi
H. Asuman Ozkara
Gönenc Ciliv
Basak Celtikci
Koksal Alptekin
Aysegul Ozerdem
Berna Kivircik Akdede
Burak Baykara
Bilge Birsoy
Gul Ergor

Progress in Neuro-Psychopharmacology and Biological Psychiatry (2008) 32 (5): 1214.